Literature DB >> 6932528

Macrophages and resistance to tumors. IV. Influence of age on susceptibility of mice to anti-inflammatory and antimacrophage effects of tumor cell products.

M Nelson, D S Nelson.   

Abstract

Supernatants from cultures of mouse tumors inhibited delayed-type hypersensitivity (DTH) reactions to sheep red blood cells (SRBC) in immunized (C57BL/6J X A/J)F1 and CBA/J mice. In mice older than 17 weeks, two activities were detectable. Material having an apparent molecular weight of less than 10,000 (by membrane filtration) inhibited only the early phase of the reactions: material having a higher molecular weight inhibited only the later phase. In younger mice, DTH reactions were not inhibited. Susceptibility of resistance could not be conferred on young or old mice by reciprocal transfer of spleen cells or sera. Only older SW or A/J mice treated with tumor supernatants displayed reduced inflammation following intradermal injection of concanavalin A (Con A) and depressed cellular responses to Con A injected ip. Supernatant fractions containing material of lower molecular weight inhibited migration and phagocytosis of opsoniazid SRBC in vitro by peritoneal macrophages from both young and old (C57BL/6J X A/J)F1 and CBA/J mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932528     DOI: 10.1093/jnci/65.4.781

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  13 in total

Review 1.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 2.  Macrophages: progress and problems.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

3.  Inhibition of cytokine production by a tumor cell product.

Authors:  E Farram; M Nelson; D S Nelson; D K Moon
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

4.  Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.

Authors:  M Nelson; D S Nelson; P B Spradbrow; V K Kuchroo; P A Jennings; G J Cianciolo; R Snyderman
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

5.  Effect of diallyl trisulfide on the activation of T cell and macrophage-mediated cytotoxicity.

Authors:  Z H Feng; G M Zhang; T L Hao; B Zhou; H Zhang; Z Y Jiang
Journal:  J Tongji Med Univ       Date:  1994

Review 6.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

7.  Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma.

Authors:  M Nelson; D S Nelson; V K Kuchroo; P B Spradbrow; P A Jennings
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 8.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

9.  I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.

Authors:  M Nelson; D S Nelson; K E Hopper
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

10.  Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope peptide.

Authors:  M Nelson; D Nelson
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.